cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Simulations Plus Inc
5 own
4 watching
Current Price
$40.43
$-1.31
(-3.14%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
821.29M
52-Week High
52-Week High
67.5899
52-Week Low
52-Week Low
32.575
Average Volume
Average Volume
0.07M
Dividend Yield
Dividend Yield
0.004426
P/E Ratio
P/E Ratio
114.9962
iconMarket Capitalization821.29M
icon52-Week High67.5899
icon52-Week Low32.575
iconAverage Volume0.07M
iconDividend Yield0.004426
iconP/E Ratio114.9962
What does the Simulations Plus Inc do?
Simulations Plus, Inc. develops and sells drug discovery and development software for mechanistic modeling and simulation. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; and KIWI, a cloud-based Web application, which organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program. Further, the company provides consulting services ranging from early drug discovery through preclinical and clinical trial data analysis, and for submissions to regulatory agencies; and population modeling and simulation contract research services for the pharmaceutical and biotechnology industries. Additionally, it offers pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, and food companies. The company distributes its products and services worldwide. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.
Read More
How much money does Simulations Plus Inc make?
News & Events about Simulations Plus Inc.
Business Wire
28days ago
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division has released DILIsym version X (DSX) Beta, the latest version of its flagship quantitative...
Ticker Report
1month ago
Simulations Plus, Inc. (NASDAQ:SLP Get Rating) Director Walter S. Woltosz sold 20,000 shares of the firms stock in a transaction that occurred on Wednesday, December 28th. The shares were sold at an average price of $36.15, for a total transaction of $723,000.00. Following the ...
Business Wire
2 months ago
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that, through a joint proposal with the University of Baths Department of Life Sciences, it has been awarded a new funded grant from the...
Business Wire
3 months ago
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that Gustavo Mendes Lima Santos has joined its Regulatory Affairs team on a one-year fellowship appointment. Mendes Lima Santos will...
Business Wire
4 months ago
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of version 9.8.3 of its flagship physiologically based biopharmaceutics (PBBM) / pharmacokinetics (PBPK) modeling platform...
Frequently Asked Questions
Frequently Asked Questions
What is Simulations Plus Inc share price today?
plus_minus_icon
Can Indians buy Simulations Plus Inc shares?
plus_minus_icon
How can I buy Simulations Plus Inc shares from India?
plus_minus_icon
Can Fractional shares of Simulations Plus Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Simulations Plus Inc stocks?
plus_minus_icon
What is today’s traded volume of Simulations Plus Inc?
plus_minus_icon
What is today’s market capitalisation of Simulations Plus Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Simulations Plus Inc?
plus_minus_icon
What percentage is Simulations Plus Inc down from its 52-Week High?
plus_minus_icon
What percentage is Simulations Plus Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$40.43
$-1.31
(-3.14%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Digital Turbine, Inc.
Digital Turbine, Inc.
$16.21
$-0.96 (-5.59 %)
eGain Corporation
eGain Corporation
$10.03
$0.08 (0.80 %)
Avid Technology Inc
Avid Technology Inc
$29.61
$-0.90 (-2.95 %)
Mitek Systems, Inc.
Mitek Systems, Inc.
$10.19
$-0.24 (-2.30 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Digital Turbine, Inc.
Digital Turbine, Inc.
$16.21
$-0.96 (-5.59 %)
eGain Corporation
eGain Corporation
$10.03
$0.08 (0.80 %)
Avid Technology Inc
Avid Technology Inc
$29.61
$-0.90 (-2.95 %)
Mitek Systems, Inc.
Mitek Systems, Inc.
$10.19
$-0.24 (-2.30 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00